Skip to main content
. 2020 Oct 27;87(1):113–124. doi: 10.1007/s00280-020-04153-6

Table 1.

Patient characteristics at baseline (= 39)

n %
Gender
 Female 22 56.4
 Male 17 43.6
Age (years)
Median (range) 56 (28–65)
 28–42 years 5 12.8
 43–65 years 34 87.2
Weight (kg), median (range) 76.0 (42.9–115.0)
Height (cm), median (range) 169.0 (149.0–187.0)
BSA (m2), median (range) 1.9 (1.4–2.3)
Heart rate (bpm), median (range) 76 (56-103)
Systolic blood pressure (mmHg), median (range) 123 (93–147)
Diastolic blood pressure (mmHg), median (range) 74 (56–86)
Body temperature (ºC), median (range) 36.6 (35.0–37.3)
ECOG PS
 0 17 43.6
 1 22 56.4
ECG
 Normal 29 74.4
 Non-significant abnormalities 10 25.6
LVEF, median (range)
 ECHO (n  = 35) 62.0 (50.0–75.0)
 MUGA (n  = 4) 65.5 (56.0–67.0)
Tumor type
 Endometrial carcinoma 9 23.1
 Head and neck carcinoma 6 15.4
 Neuroendocrine tumors 5 12.8
 Small cell lung cancer 5 12.8
 Biliary tract carcinoma 4 10.3
 Ewing’s family of tumors 3 7.7
 Germ cell tumor 3 7.7
 BRCA 1/2-associated metastatic breast carcinoma 2 5.1
 Carcinoma of unknown primary site 2 5.1

bpm beats per minute, BSA body surface area, ECG electrocardiogram, ECHO echocardiography, ECOG PS Eastern Cooperative Oncology group performance status, LVEF left-ventricular ejection fraction, MUGA multiple-gated acquisition scan